Appendix 2: Office of Health Economics Briefing: Challenges and Opportunities for Improving Benefit–Risk Assessment of Pharmaceuticals from an Economic Perspective– James Cross and Louis Garrison (August 2008)
2016 ◽
Vol 13
(1)
◽
pp. 55-78
◽
Keyword(s):
Keyword(s):
Keyword(s):
2019 ◽
Vol 53
(5)
◽
pp. 630-638
◽